25 May 2013
Keywords: pharmacyclics, ph, iii, trial, mri, agent, initiated
Article | 03 October 1994
Pharmacyclics has initiated a Phase III trial of its Gadolite oral
suspension magnetic resonance imaging agent in the diagnosis of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 October 1994
24 May 2013
© 2013 thepharmaletter.com